Press Release Jun 30 2021

Published July 1, 2021 at 2:38 a.m. UTC

Unichem Laboratories Limited has informed the Exchange regarding a press release dated Jun 30, 2021, titled "Press release pertaining to receipt of Tentative Approval for ANDA from United States Food and Drug Administration (USFDA) for Aripiprazole Tablets".

View Attachment

4:["$","main",null,{"className":"seo-shell seo-template-news","children":[["$","script",null,{"type":"application/ld+json","className":"seo-jsonld","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Press Release Jun 30 2021\",\"description\":\"Unichem Laboratories Limited has informed the Exchange regarding a press release dated Jun 30, 2021, titled \\\"Press release pertaining to receipt of Tentative Approval for ANDA from United States Food and Drug Administration (USFDA) for Aripiprazole Tablets\\\".\",\"url\":\"https://6ix.com/news/press-release-jun-30-2021-13\",\"datePublished\":\"2021-07-01T02:38:17.000Z\",\"articleSection\":\"Business\",\"about\":{\"@type\":\"Corporation\",\"name\":\"Unichem Laboratories Limited\",\"url\":\"https://6ix.com/stock/nse-unichemlab/unichem-laboratories-limited\",\"tickerSymbol\":\"NSE:UNICHEMLAB\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"6ix\",\"url\":\"https://6ix.com\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https://6ix.com/images/social-banner.png?v=2\"}}}"}}],["$","div",null,{"className":"seo-page-frame","children":[null,[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"$d"}}],["$","div",null,{"dangerouslySetInnerHTML":{"__html":"$e"}}]]]}]]}] 7:null